PEOPLE - UroMed (US) makes promotion:
This article was originally published in Clinica
Executive Summary
US company UroMed, which markets interventional urological products with a focus on treatments for prostate cancer, has promoted Daniel Muscatello to president and CEO. He succeeds John Simon, who continues as chairman.